Show simple item record

dc.contributor.authorChotikanatis, Kobkul
dc.contributor.authorSuman, Nisha
dc.contributor.authorBäcker, Martin
dc.contributor.authorPaudyal, Bandana
dc.contributor.authorSchoeneman, Morris
dc.contributor.authorKohlhoff, Stephan
dc.contributor.authorHammerschlag, Margaret R
dc.date.accessioned2023-07-07T16:39:18Z
dc.date.available2023-07-07T16:39:18Z
dc.date.issued2015-12
dc.identifier.citationChotikanatis K, Suman N, Bäcker M, Paudyal B, Schoeneman M, Kohlhoff S, Hammerschlag MR. Pediatric Fistula Initiative: Reducing Bloodstream Infections in an Outpatient Pediatric Hemodialysis Center. J Pediatric Infect Dis Soc. 2015 Dec;4(4):363-6. doi: 10.1093/jpids/piu053. Epub 2014 Jun 10. PMID: 26582876.en_US
dc.identifier.eissn2048-7207
dc.identifier.doi10.1093/jpids/piu053
dc.identifier.pmid26582876
dc.identifier.urihttp://hdl.handle.net/20.500.12648/10399
dc.description.abstractBloodstream infection is a major contributor to morbidity and mortality in children on hemodialysis (HD). From January 2009 through April 2011, the incidence of access-related bloodstream infections (ARBs) in pediatric patients on HD at our hospital was 3.45/1000 patient days. Almost all of these children were receiving HD via central line catheters, and none were receiving HD via arteriovenous fistulas (AVFs). In an effort to reduce the rate of infection in children receiving HD at our institution, we introduced the Pediatric Fistula Initiative, a program to increase creation and use of AVFs in children. Thirty-three children on HD were observed, 9 of whom received AVFs during the study period. The incidence of ARBs decreased to 1.30/1000 patient days (P < .001) during the 24-month intervention period from May 2011 through May 2013.
dc.language.isoenen_US
dc.relation.urlhttps://academic.oup.com/jpids/article/4/4/363/2579951en_US
dc.rights© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCRBSIsen_US
dc.subjectPediatric Fistula Initiativeen_US
dc.subjectaccess-related bloodstream infectionsen_US
dc.subjectarteriovenous fistulasen_US
dc.subjectcatheter-related bloodstream infectionsen_US
dc.subjecthemodialysisen_US
dc.titlePediatric Fistula Initiative: Reducing Bloodstream Infections in an Outpatient Pediatric Hemodialysis Center.en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleJournal of the Pediatric Infectious Diseases Societyen_US
dc.source.volume4
dc.source.issue4
dc.source.beginpage363
dc.source.endpage6
dc.source.countryEngland
dc.description.versionVoRen_US
refterms.dateFOA2023-07-07T16:39:21Z
html.description.abstractBloodstream infection is a major contributor to morbidity and mortality in children on hemodialysis (HD). From January 2009 through April 2011, the incidence of access-related bloodstream infections (ARBs) in pediatric patients on HD at our hospital was 3.45/1000 patient days. Almost all of these children were receiving HD via central line catheters, and none were receiving HD via arteriovenous fistulas (AVFs). In an effort to reduce the rate of infection in children receiving HD at our institution, we introduced the Pediatric Fistula Initiative, a program to increase creation and use of AVFs in children. Thirty-three children on HD were observed, 9 of whom received AVFs during the study period. The incidence of ARBs decreased to 1.30/1000 patient days (P < .001) during the 24-month intervention period from May 2011 through May 2013.
dc.description.institutionSUNY Downstateen_US
dc.description.departmentPediatricsen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalJournal of the Pediatric Infectious Diseases Society
dc.identifier.issue4en_US


Files in this item

Thumbnail
Name:
piu053.pdf
Size:
95.47Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Except where otherwise noted, this item's license is described as © The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.